ANGO Financial Facts
Gross profit: 41.2MTotal other income (expenses): -1.88M
See Full Income Statement
Retained earnings: 30.43M
Accrued liabilities: 20.58M
See Full Balance Sheet
Earnings History for AngioDynamics (ANGO)
|
Expand Research on ANGO
| Next EPS Date | 7/11/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/7/10 | Q111 | $0.08 | $0.08 | $0.00 | N/A | N/A | N/A / N/A | = | -27.7% | Details | |
1/4/11  |
 |
Q211 | $0.13 | $0.12 | +$0.01 | $53.4M | $54.37M | N/A / N/A | = | -30.4% | Details |
| 4/5/11 |
|
Q311 | $0.15 | $0.12 | +$0.03 | $54.6M | $53.89M | N/A / N/A | = | -28.6% | Details |
| 7/14/11 |
|
Q411 | -$0.03 | $0.10 | -$0.13 | $56.4M | $56.96M | N/A / N/A | = | -24.2% | Details |
| 10/6/11 |
|
Q112 | $0.08 | $0.08 | $0.00 | $54.4M | $53.86M | N/A / N/A | = | -23.8% | Details |
| 1/5/12 |
|
Q212 | $0.13 | $0.12 | +$0.01 | $53.4M | $56.26M | N/A / N/A | = | -26.7% | Details |
| 4/4/12 |
|
Q313 | $0.09 | $0.08 | +$0.01 | $51.6M | $51.34M | N/A / N/A | = | -12.7% | Details |
| 7/12/12 |
|
Q412 | $0.10 | $0.09 | +$0.01 | $57.7M | $52.97M | N/A / N/A | = | -5% | Details |
